Winkler, Julia K.
Schiller, Matthias
Bender, Carolin
Enk, Alexander H.
Hassel, Jessica C.
Article History
Received: 24 April 2017
Accepted: 1 March 2018
First Online: 7 March 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The institutional review board of the Medical Faculty of the University Hospital of Heidelberg (S-454/2015) approved the retrospective institutional patient data analysis. Guidelines from the Declaration of Helsinki were followed.
: All patients gave written informed consent to individual treatment with rituximab. They were informed that therapy with rituximab is experimental and has not been approved for melanoma treatment.